3YA-23831-60002
3 vaccinations
1 coded response
18 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 176 / PA
- Registered
- 2021-05-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-16
Dose 1 — Pfizer-BioNTech
-
2021-05-07
Registered in v-safe
-
2021-05-07
Dose 2 — Pfizer-BioNTech
-
2021-05-07
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-13
-
2021-05-15
Health check-in — day 7, dose 2Feeling: Fair · Fever · Chills, Headache · Be unable to workAdult check-in
- 2021-05-23
- 2021-05-30
- 2021-06-04
- 2021-06-11
- 2021-06-18
- 2021-08-06
- 2021-11-07
-
2022-01-31
Dose 3 — Pfizer-BioNTech
-
2022-05-02
Survey response — 3 months, dose 3MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-05-02
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-03
-
2022-05-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-08-03
- 2023-01-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-16 | Pfizer-BioNTech | |
| 2 | 2021-05-07 | Pfizer-BioNTech | |
| 3 | 2022-01-31 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-02 | Successful 2022-05-06 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 11 — 3 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release